Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Kato S, Tsujimoto SI, Matsubayashi J, Iwamoto S, Hiramatsu H, Okuno Y, Kamitori T, Ohki K, Deguchi T, Kiyokawa N, Kato M, Takita J, Tanaka S, Adachi S, Tomizawa D, Shiba N. Kato S, et al. Among authors: tsujimoto si. Haematologica. 2024 Sep 5. doi: 10.3324/haematol.2024.286243. Online ahead of print. Haematologica. 2024. PMID: 39234860 Free article.
Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study.
Sakaguchi H, Taga T, Ishida H, Hama A, Okamoto Y, Sano H, Sato M, Koga Y, Koh K, Iwasaki F, Yoshida N, Cho Y, Okada K, Watanabe K, Watanabe A, Hasegawa D, Noguchi M, Hashii Y, Matsumoto K, Tabuchi K; Pediatric Acute Myeloid Leukemia Working Group of Japanese Society for Transplantation and Cellular Therapy. Sakaguchi H, et al. Bone Marrow Transplant. 2024 Nov;59(11):1621-1624. doi: 10.1038/s41409-024-02396-y. Epub 2024 Aug 22. Bone Marrow Transplant. 2024. PMID: 39174743 No abstract available.
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Yoshitomi M, Tsujimoto SI, Ikeda J, Kawai T, Ohki K, Hara Y, Yamato G, Tanoshima R, Tomizawa D, Shimada A, Horibe K, Adachi S, Taga T, Tawa A, Hayashi Y, Ito S, Shiba N. Yoshitomi M, et al. Among authors: tsujimoto si. Pediatr Blood Cancer. 2024 Sep;71(9):e31151. doi: 10.1002/pbc.31151. Epub 2024 Jul 2. Pediatr Blood Cancer. 2024. PMID: 38953149
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.
Iyoda S, Yoshida K, Shoji K, Ito N, Tanaka M, Nannya Y, Yamato G, Tsujimoto S, Shiba N, Hayashi Y, Shiozawa Y, Shiraishi Y, Chiba K, Okada A, Tanaka H, Miyano S, Koga Y, Goto H, Moritake H, Terui K, Ito E, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Takita J, Nishikori M, Adachi S, Ogawa S, Matsuo H. Iyoda S, et al. Among authors: tsujimoto s. Leukemia. 2024 Jul;38(7):1609-1612. doi: 10.1038/s41375-024-02244-4. Epub 2024 Apr 18. Leukemia. 2024. PMID: 38632314 No abstract available.
302 results